Document Detail

The role of diet on the clinical pharmacology of oral antineoplastic agents.
MedLine Citation:
PMID:  21796375     Owner:  NLM     Status:  Publisher    
PURPOSE: The number of oral anticancer agents has greatly increased in recent years. It is a well-known fact that food intake can induce significant variations in the bioavailability of these drugs. The aim of this review is to describe the interactions between diet and oral anticancer drugs in terms of the possible effects of such interactions on reducing the antineoplastic activity of the drug or increasing its side effects. METHODS: This was an analytical study of the numerous mechanisms leading to changes in the bioavailability of oral antineoplastic agents due to diet. RESULTS: Food-drug interactions can induce a delay, decrease or increase in the absorption of the oral chemotherapeutic agent. The concomitant intake of food and antineoplastic drugs influence the pharmacokinetic and pharmacodynamic drug processes depending on the composition of the food consumed and the specific interactions of the food with transport mechanisms (p-glycoprotein, multidrug resistance proteins) and intestinal enzymatic systems (cytochrome P450). CONCLUSIONS: In prescribing an oral anticancer agent, clinicians must consider the possibility that the consumption of specific food items has the potential to interfere with the pharmacokinetics and pharmacodynamics of the prescribed drug.
Antonio Ruggiero; Maria G Cefalo; Paola Coccia; Stefano Mastrangelo; Palma Maurizi; Riccardo Riccardi
Related Documents :
16358525 - Food safety and environmental issues in animal welfare.
3734745 - Experimental study of postmortem change under field conditions: effects of freezing, th...
2887175 - Alprazolam dependence in mice.
21953745 - Recognition and uptake of free and nanoparticle-bound betalactoglobulin - a food allerg...
11582835 - Guidelines for the intake of vegetables and fruit: the mediterranean approach.
17928695 - Specific detection of wheat residues in processed foods by polymerase chain reaction.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-7-28
Journal Detail:
Title:  European journal of clinical pharmacology     Volume:  -     ISSN:  1432-1041     ISO Abbreviation:  -     Publication Date:  2011 Jul 
Date Detail:
Created Date:  2011-7-28     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  1256165     Medline TA:  Eur J Clin Pharmacol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Division of Paediatric Oncology, Catholic University of Rome-A. Gemelli Hospital, Largo A. Gemelli 8, 00168, Rome, Italy,
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Absenteeism Screening Questionnaire (ASQ): A New Tool for Predicting Long-term Absenteeism Among Wor...
Next Document:  Optimal dose finding of garenoxacin based on population pharmacokinetics/pharmacodynamics and Monte ...